Katheterablation von Vorhofflimmern

Pulmonalvenenisolation mit einem neuen multipolaren Ablationskatheter
Article
  • 41 Downloads

Zusammenfassung

Die Katheterablation von Vorhofflimmern (VHF) hat sich in den letzten Jahren zunehmend in der Behandlung vor allem des paroxysmalen Vorhofflimmerns etabliert. In dieser Arbeit werden die Ergebnisse mit dem Einsatz des PVAC-Multielektroden-Ablationskatheters (PVAC®, Medtronic Ablation Frontiers, Carlsbad, CA, USA) vorgestellt. Insgesamt 253 Patienten mit paroxysmalem und persistierendem Vorhofflimmern wurden in die Studie aufgenommen. Es wurden insgesamt 1051 Pulmonalvenen (PV) isoliert, darunter auch 34 gemeinsame Ostien links und 1 gemeinsames Ostium rechts abladiert. Bis auf eine Vene konnten bei allen Patienten alle Zielvenen elektrisch isoliert werden. Bei 23 Patienten (9 %) wurde bei dokumentiertem typischen Vorhofflattern in gleicher Sitzung zusätzlich auch der rechtsatriale Isthmus abladiert. Nachkontrollen fanden jeweils 1, 3, 6 und 12 Monate nach der Ablation mittels 12-Kanal-EKG, Langzeit-EKG sowie 4-Tages-Holter-EKG statt. Belastbare Nachbeobachtungsdaten lagen von 221 Patienten vor. In einer Follow-up-Zeit von 11 ± 7 Monaten und mit einer Eingriffshäufigkeit von 1,1 pro Patient (24 Redo-Fälle) waren 122 von 181 (69 %) der Patienten mit paroxysmalem Vorhofflimmern im stabilen Sinusrhythmus; bei den Patienten mit persistierendem Vorhofflimmern waren es 23 von 40 (58 %). Insgesamt 159 Patienten (62,8 %) nahmen zum Zeitpunkt des letzten Follow-ups Antiarrhythmika ein; 214 Patienten hatten einen Betablocker (84,5 %). Die Durchleuchtungszeit betrug 16 ± 6 min bei einer Gesamtprozedurdauer von 71 ± 19 min. Prozedurbezogene Komplikationen wurde in 3 Fällen (1,2 %) beobachtet. Die Pulmonalvenenisolation mit dem PVAC-Ablationskatheter ist eine sichere, effektive und schnelle Methode zur Behandlung von paroxysmalem und persistierendem Vorhofflimmern.

Schlüsselwörter

Katheterablation Vorhofflimmern Pulmonalvenenisolation 

Catheter ablation of atrial fibrillation

Pulmonary vein isolation by using a new multipolar ablation catheter

Abstract

Catheter ablation of atrial fibrillation (AF) is an established therapeutical option, particularly in treatment of paroxysmal atrial fibrillation. This paper presents the results of using the PVAC multi-electrode ablation catheter (PVAC®, Medtronic Ablation Frontiers, Carlsbad, CA, USA). In 253 patients with paroxysmal or persistant AF, 1051 pulmonary veins were isolated, including ablation of 34 left common ostia and 1 right common ostium. Except one vein, all pulmonary veins in all patients were successfully isolated. In 23 patients with documented typical atrial flutter, the right atrial isthmus was additionally ablated within the same procedure. Follow-up (FU) visits were performed after 1, 3, 6 and 12 months with 12-lead-ECG, 24h-Holter-ECG and 4-days-Holter ECG. Mean FU was 11 ± 7 months with 1.1 interventions per patient (24 redo cases). During FU, 122 of 181 patients with paroxysmal AF (69%) and 23 of 40 patients with persistant AF (58%) were in stable sinus rhythm (SR) after ablation. 159 (62.8%) patients wer under antiarrhythmic drugs after ablation, 214 (84.5%) patients with additional β-blockers. Total procedure time was 71 ± 19 min, and total fluoroscopy time was 16 ± 6 min. In 3 cases (1.2%) procedure-related complications occured. Pulmonary vein isolation by using the PVAC-ablation catheter is a safe and effective method in treatment of paroxysmal and persistant AF.

Keywords

Catheter ablation Atrial fibrillation Pulmonary vein isolation 

Notes

Interessenkonflikt

Die Autoren geben an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults – national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285:2370–2375PubMedCrossRefGoogle Scholar
  2. 2.
    Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedGoogle Scholar
  3. 3.
    European Heart Rhythm Association, Heart Rhythm Society, Fuster V, Ryd ́en LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL (2006) For the American College of Cardiology, American Heart Association Task Force on practice guidelines, European Society of Cardiology Committee for practice guidelines, Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation. ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 48:854–906Google Scholar
  4. 4.
    Guidelines for the management of atrial fibrillation (2010) The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429Google Scholar
  5. 5.
    Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul S, Punlee K, Kangkagate C (2003) A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 86(Suppl 1):S8–S16PubMedGoogle Scholar
  6. 6.
    Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F (2006) Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354:934–941PubMedCrossRefGoogle Scholar
  7. 7.
    Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A (2005) Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment for symptomatic atrial fibrillation. JAMA 293:2634–2640PubMedCrossRefGoogle Scholar
  8. 8.
    Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF (2006) Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study). Eur Heart J 27:216–221PubMedCrossRefGoogle Scholar
  9. 9.
    Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M (2008) Catheter ablation versus antiarhythmic drugs for atrial fibrillation. The A4 study. Circulation 118:2498–2505PubMedCrossRefGoogle Scholar
  10. 10.
    Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V (2006) A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF (ablation for paroxysmal atrial fibrillation) study. J Am Coll Cardiol 48:2340–2347PubMedCrossRefGoogle Scholar
  11. 11.
    Forleo GB, Mantica M, de Luca L, Leo R, Santini L, Panigada S, De Sanctis V, Pappalardo A, Laurenzi F, Avella A, Casella M, Della Russo A, Romeo F, Pelargonio G, Tondo C (2009) Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 20:22–28PubMedCrossRefGoogle Scholar
  12. 12.
    Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AF Trial Investigators (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303:333–340Google Scholar
  13. 13.
    Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, Kurzidim K, Berkowitsch A, Koller M, Heintze J, Scholz U, Wetzel U, Schneider MA, Horstkotte D, Hamm CW, Pitschner HF (2008) Circumferential pulmonary vein isolation with the cryoballoon technique: results from a prospective 3-center study. J Am Coll Cardiol 52:273–278PubMedCrossRefGoogle Scholar
  14. 14.
    Cheema A, Dong J, Dalal D, Vasamreddy CR, Marine JE, Henrikson CA, Spragg D, Cheng A, Nazarian S, Sinha S, Halperin H, Berger R, Calkins H (2006) Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation. J Cardiovasc Electrophysiol 17:1080–1085PubMedCrossRefGoogle Scholar
  15. 15.
    Hocini M, Sanders P, Jaïs P, Hsu LF, Takahashi Y, Rotter M, Clémenty J, Haïssaguerre M (2004) Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 15:1467–1471PubMedCrossRefGoogle Scholar
  16. 16.
    Verma A, Patel D, Famy T, Martin DO, Burkhardt JD, Elayi SC, Lakkireddy D, Wazni O, Cummings J, Schweikert RA, Saliba W, Tchou PJ, Natale A (2007) Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation. J Cardiovasc Electrophysiol 18:151–156PubMedCrossRefGoogle Scholar
  17. 17.
    Bulava A, Haniš J, Sitek D, Ošmera O, Karpianus d, Snorek M, Rehoušková K, Toušek F, Peši L (2010) Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing Clin Electrophysiol 33:1039–1046PubMedCrossRefGoogle Scholar
  18. 18.
    Wieczorek M, Hoeltgen R, Akin E, Salili AR, Oral H, Morady F (2010) Results of short-term and long-term pulmonary vein isolation for paroxysmal atrial fibrillation using duty-cycled bipolar and unipolar radiofrequency energy. J Cardiovasc Electrophysiol 21:399–405PubMedCrossRefGoogle Scholar
  19. 19.
    Fredersdorf S, Weber S, Jilek C, Heinicke N, von Bary C, Jungbauer C, Riegger GA, Hamer OW, Jeron A (2009) Safe and rapid isolation of pulmonary veins using a novel circular ablation catheter and duty-cycled RF generator. J Cardiovasc Electrophysiol 20:1097–1101PubMedCrossRefGoogle Scholar
  20. 20.
    Dang L, Oral H, Morady F, Candinas R, Scharf C (2008) Low energy phased radiofrequency for multielectrode ablation of paroxysmal atrial fibrillation (abstract). Heart Rhythm 5(Suppl):18Google Scholar
  21. 21.
    Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880PubMedCrossRefGoogle Scholar
  22. 22.
    Tivig Ch, Dang L, Brunner-La Rocca H-P, Özcan S, Duru F, Scharf Ch (2010) Duty-cycled unipolar/bipolar versus conventional radiofrequency ablation in paroxysmal and persistent atrial fibrillation. Int J Cardiol. doi:10.1016/J.ijcard.2010.12.010Google Scholar
  23. 23.
    Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi E, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38PubMedCrossRefGoogle Scholar
  24. 24.
    Packer D, Irwin JM, Champagne J, Guerra PG, Dubuc M, Wheelan KR, Kowal RC, Reddy V, Lehmann JW, Holcomb RG, Ruskin JN for the STOP-AF Cryoablation Investigators (2010) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation. First results of the North American Arctic Front STOP-AF-Pivotal trial. Presentation at the American College of Cardiology Meeting, Atlanta, 15 March 2010Google Scholar
  25. 25.
    De Greef Y, Tavnier R, Duytschaever M, Stockman D (2010) Pulmonary vein isolation with the 30 and 35 mm high-density mesh ablator. Europace 12:1428–1434PubMedCrossRefGoogle Scholar
  26. 26.
    Natale A, Pisano E, Shewchik J, Bash D, Fanelli R, Potenza D, Santarelli P, Schweikert R, White R, Saliba W, Kanagaratnam L, Tchou P, Lesh M (2000) First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 102:1879–1882PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Praxisklinik Herz und Gefäße, Kardiologie-Angiologie-Radiologie-NuklearmedizinAkademische Lehrpraxisklinik der TU DresdenDresdenDeutschland

Personalised recommendations